Thursday, July 10, 2014

Top 10 Sliver Stocks To Buy Right Now

Top 10 Sliver Stocks To Buy Right Now: AspenBio Pharma Inc.(APPY)

AspenBio Pharma, Inc. operates as an emerging biomedical company focused on obtaining the United States FDA clearance for its lead product, AppyScore. Its research and development activities primarily focus on a human appendicitis blood-based test. The company?s lead product candidate, AppyScore, is a blood-based diagnostic test to help physicians manage patients who enter emergency rooms complaining of abdominal pain and suspected of having acute appendicitis. It is also developing animal healthcare products focusing on reproduction. The company was formerly known as AspenBio, Inc. and changed its name to AspenBio Pharma, Inc. on September 26, 2005. AspenBio Pharma, Inc. was founded in 2000 and is based in Castle Rock, Colorado.

Advisors' Opinion:
  • [By Monica Gerson]

    Venaxis (NASDAQ: APPY) soared 22.83% to $3.33 in the pre-market trading on positive top-line results from pivotal study of APPY1 test.

    Plug Power (NASDAQ: PLUG) shares gained 11.18% to $7.56 in the pre-market after the company reported fourth-quarter results. Plug Power posted a quarterly loss of $0.08 per share, versus the estimated loss of $0.08 per share.

  • [By James E. Brumley]

    To tell the truth, I'm not the least bit surprised that I'm chiming in on Venaxis Inc. (NASDAQ:APPY) today. It was a stock I dissected just two days ago (on Tuesday - here's that chat), pointing out how all the telltale signs of bullishness were brewing. Sure enough, APPY popped on Wednesday, and as a result has gone from a mere potential big mover to an actual mover.

  • [By James E. Brumley]

    I know on the surface that Venaxis Inc. (NASDAQ:APPY) hasn't exactly been the most riveting of stocks lately. Heck, APPY shares are exactly where they were at the end of July, and volume has been even less than minimal. I'm telling you though, there's just something about this stock - and its chart - that tells! me an explosive bullish move is brewing.

  • [By Lee Jackson]

    Vernaxis Inc. (NASDAQ: APPY) is an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE MarkedAPPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis. They have moved ahead with their pivotal trial enrollment, and the analyst at Canaccord Genuity rates the company as a stock to buy. Its price target for the stock is a whopping $7, the high target for the stock. A move to that level would represent a 250% move for shareholders. The consensus target is at $5.25.Vernaxis closed Friday at $1.97.

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-10-sliver-stocks-to-buy-right-now.html

No comments:

Post a Comment